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Abstract 
 
Resonant chalcogenpyrylium nanotags demonstrate an exceptional surface enhanced 
Raman scattering (SERS) performance for use in SORS applications. Using surface 
enhanced spatially offset Raman spectroscopy (SESORS), nanotags modified with a 
chalcogenpyrylium dye were observed at concentrations as low as 1 pM through 5 
mm of tissue. Calculated limits of detection suggest that these SERS nanotags can be 
detected at 104 fM using surface enhanced spatially offset resonance Raman 
scattering (SESORRS) demonstrating their potential for in vivo applications.   
 
Introduction 
 
The ability to detect low levels of analytes through barriers in a sensitive and non-
destructive manner is a challenge faced in both the security and biomedical fields.1 
Raman spectroscopy provides a means to solving this challenge since it measures a 
unique chemical fingerprint that can distinguish between signals from the barrier and 
the analyte without the need to destroy the sample, however it is often limited in its 
ability to detect analytes at depth.2 Spatially offset Raman spectroscopy (SORS) is an 
emerging technique which is capable of providing spectral information on the analyte 
under study, even when obscuring barriers such as tissue are present.3 SORS relies 
on the idea that photons generated at depth undergo multiple diffuse scattering 
processes, and thus travel laterally upon return to the collection probe.2 Unlike 
conventional 180˚ backscattering techniques, where excitation and collection typically 
take places at the same point, SORS makes use of a spatial offset between the point 
of laser excitation and the point of collection.2 By exploiting the use of a spatial offset 
between the point of incident light and the point of collection, it is possible to obtain 
Raman signal of the photons generated at depth, i.e. the analyte obscured by the 
barrier.4 Since first reported by Matousek et al.,2 SORS has been applied to a number 
of applications including security,4–7 the detection of counterfeit alcohol8 and the 
monitoring of the quality of red blood cells.9 Perhaps more importantly, the introduction 
of SORS has opened up new avenues for medical applications; in particular non-
invasive disease diagnostics. Several reports have explored the use of SORS for the 
assessment of bone10, allowing information on both the inorganic and organic 
components of bone to be ascertained,3 as well as in the non-invasive assessment of 
calcifications associated with breast cancer.11 
 
Surface enhanced Raman spectroscopy (SERS) is useful for overcoming the 
limitations associated with conventional Raman spectroscopy. By functionalising 
nanoparticles (NPs) with a molecularly specific Raman reporter, greater enhancement 
in the inelastic scattering of the Raman reporter can be achieved.12 Surface enhanced 
resonance Raman spectroscopy (SERRS) makes use of a Raman reporter with an 
electronic transition close to that of the laser excitation wavelength and generates 
further enhancement in Raman signal.13 SERS has been used extensively in 
biomedical imaging applications and nanotags functionalised with biomolecules such 
as antibodies have assisted in the targeted imaging of numerous cancers in vivo 
including ovarian14 and esophageal.15  
 
Surface enhanced spatially offset Raman spectroscopy (SESORS) encompasses 
both the SERS and SORS techniques16 and, whilst not a completely non-invasive 
technique as the NPs must be introduced, it does achieve considerable enhancement 
in Raman signal at larger, more clinically relevant depths. Since it was first reported 
by Stone et al.,16 SERS active nanotags have been tracked through depths of up to 
50 mm of tissue using a transmission optical approach.17 Using a backscattering 
geometry, SESORS has been used in glucose sensing,18 in the tracking of nanotags 
through 8 mm of bone19 and in the detection of neurotransmitters in the skull.20 
 
Previous work in our group has reported the technique of surface enhanced spatially 
offset resonance Raman spectroscopy (SESORRS), which demonstrates the benefit 
of using a resonant Raman reporter for superior levels of depth penetration. 21 In this 
instance, SERRS active nanotags were detected through 25 mm of porcine tissue and 
the same nanotags were taken up into ex vivo breast cancer models and detected 
through 15 mm of tissue using a handheld SORS spectrometer.21,22 Such depth 
penetration was achieved through the use of chalcogenpyrylium Raman reporters with 
a tuneable absorption maxima in the near infrared (NIR). We have also demonstrated, 
using both conventional Raman23 and SORS, 21 that by using a Raman reporter that 
is in resonance with the laser excitation wavelength, it is possible to detect SERS 
nanotags through larger thicknesses in comparison to when non-resonant Raman 
reporters are used. Previous reports have shown these reporter molecules to be 
particularly useful at longer wavelengths including 1280 nm24 and 1550 nm25, 
outperforming commercially available Raman reporter molecules such as BPE.  
 
In recent years, focus has shifted towards the use of handheld Raman instrumentation, 
mainly due to portability, ease of use and typically lower cost.26 Previous work in the 
SESORS field has typically focused on the depth penetration capabilities of the 
technique, i.e. the focus has been to probe through significant depth. However, few 
studies have investigated the minimum nanoparticle (NP) concentration that can be 
detected at a given tissue thickness. This is a key question that needs to be addressed 
if SESORS is to translate into the clinic where the number of nanoparticles found at a 
targeted site, for example, a tumour, may be low. As such, the work presented here 
explores the benefit of using resonant Raman reporters for low limits of detection of 
SERRS nanotags through tissue using a handheld SORS instrument.   
 
Experimental  
Materials and Methods 
 
All chemicals and small molecule Raman reporters were purchased from Sigma 
Aldrich unless otherwise stated. AuNPs with an average diameter of 78 nm were 
synthesized using a seeded method and left to stir overnight.27 Briefly, gold seeds of 
26 nm were synthesized using the citrate reduction method. Sodium tetrachloroaurate 
(III) dihydrate (681 µL, final concentration 0.254M) and sodium citrate trihydrate (528 
µL, final concentration 0.171M) were added to 5.007 ml of 28 nm seeds and made up 
to 120 ml with dH2O. The solution was left to stir overnight. NPs were characterized 
using extinction spectroscopy and had an LSPR of 548 nm.  
A chalcogenpyrylium-based dye was synthesized according to previously reported 
methods.24,25,28 Dye 823 was prepared by dissolving the solid in anhydrous N,N-
Dimethylformamide (DMF, 99.8%) to produce a 1 mM stock. Subsequent dilutions 
were then carried out using DMF and dH2O (50:50). Raman reporter 1,2-bis(4-
pyridyl)ethylene (BPE) was prepared by dissolving the solid in ethanol to produce a 
10 mM stock. Subsequent dilutions were carried out using dH2O. Dye 823 was 
characterized using extinction spectroscopy (Agilent Cary 60) to determine the λmax. 
BPE is a non-resonant Raman reporter.  
Measurements were taken using a handheld Resolve instrument from Cobalt Light 
Systems (830 nm, average laser power 450 mW). All measurements were carried out 
using a 2 s integration time, 5 accumulations and an 8 mm offset. The nose cone was 
fitted to use the instrument in a contact mode setting. The handheld instrument used 
here has a fixed exposure time. Measurements were carried out using 3 samples. 
Prior to dye addition, NPs were concentrated by centrifugation (1 mL aliquots, 5000 
RPM, 10 mins) and resuspended in 500 µL of water.  
 
Experimental set up 
 
Pork loin tissue was obtained from a local butcher and cut into sections (roughly 3.5 
cm inches x 4 cm with varying thicknesses). Pork was chosen as an analogue to 
human samples due its ability to mimic human tissue greater than that from avian 
species.16 LOD experiments were performed using quartz cuvettes. 350 µL of each 
nanotag solution was pipetted into a Suprasil quartz micro cuvette, path length 1 mm, 
chamber volume 350 µL. Tissue samples of varying thicknesses were then placed in 
front of the cuvette. The nose cone was brought into contact with the tissue samples, 
thus ensuring there was no space between the instrument and the tissue. The set up 
involving the cuvette is shown in Error! Reference source not found..  
Investigation of the nanotags for LODs using SESORS was carried out by adding each 
reporter (3 uL, 300 µM) to 500 µL of NPs. The solution was then made up to 1 mL with 
dH2O. An initial final dye concentration of 300 nM was used for each nanotag solution, 
thus by keeping the dye concentration as low as possible the benefit of using a Raman 
reporter which is in resonance with the laser was exploited. Nanotag solutions were 
subsequently diluted from 11 pM to 900 fM and SESORS spectra through 5 mm of 
tissue were obtained. The solutions were diluted using deionised water. The limit of 
detection (LOD) was calculated to be 3 times the standard deviation of the blank, 
divided by the gradient of the straight line of best fit. Error bars represent one standard 
deviation resulting from 3 replicate samples and 5 scans of each.  
Data processing 
All spectra were processed using Matlab software (Version 2017a, The MathWorks, 
Natrick, MA, USA). Preprocessing involved truncating and baselining the spectra.  
 
 
Results and Discussion 
 
To investigate the advantage of using resonant molecules for improved limits of 
detection of nanotags, gold nanoparticles (AuNPs) were synthesised according to 
previously reported methods.24 The resulting particles had an average diameter of 78 
nm. AuNPs were functionalised with either a resonant chalcogenpyrylium Raman 
reporter, dye 823, or the commercially available small molecule reporter 1,2-bis(4-
pyridyl)ethylene, BPE, to create nanotags. Dye 823 is named according to its 
absorption maximum, i.e. it absorbs at 823 nm, making it resonant with the incident 
laser light of 830 nm. The resonance capabilities are controlled using previously 
reported methods.25,24 BPE is a non-resonant small molecule which is often used in 
SERS applications. It has previously been shown that when a solution of nanotags is 
obscured by a tissue barrier, superior SERS signal is generated through the use of 
resonant Raman reporter molecules compared to non-resonant small molecule such 
as BPE.21 In order to demonstrate the advantage of using a resonant Raman reporter 
molecule over a non-resonant reporter for improved limits of detection (LOD) using 
SESORS, the ability to detect nanotag solutions containing either BPE or dye 823 at 
varying concentrations was explored. Solutions of the nanotags were held in a quartz 
microcuvette and obscured by 5 mm of porcine tissue and the peak intensity of the 
most intense peak that corresponded to the reporter molecule in the offset spectra 
was measured. Significant enhancement in signal was generated through the use of 
a resonant Raman reporter compared to off resonant molecules. BPE however was 
shown to offer improved SERS signal through the tissue barrier in comparison to 
another commercially available non-resonant small molecule, azopyridine (AZPY).21 
The corresponding SERS spectra and chemical structure of the two Raman reporters 
are shown in Figure 1, a reference spectrum of the tissue is also displayed.  
 
 Figure 1 – (a) SERS spectra of the two Raman reporters used in this work, BPE (bottom) and dye 823 
(middle), as well as a Raman spectrum of the tissue as a reference (top). Dye 823 is a resonant chalcogen 
based Raman reporter and BPE is commercially available non-resonant small molecule Raman reporter. 
Spectra were obtained using the SORS instrument in a conventional Raman mode. All measurements were 
carried out using a 2 s integration time, 5 accumulations, 830 nm laser excitation wavelength. Chemical 
structure of dye 823 (b) and BPE (c).  
 
Particle dilution studies were conducted in order to calculate a limit of detection for 
both nanotag solutions through 5 mm of tissue using SESORS. Each of the two Raman 
reporters were added to AuNPs to create nanotag solutions with a final dye 
concentration of 300 nM. The aim was to keep the dye concentration as low as 
possible by exploiting the benefit of using a Raman reporter that is in resonance with 
the laser. It should be noted that in these studies no inorganic salt was added to the 
nanotags to enhance the SERS response through the creation of “hot spots”.29 The 
concentration of the nanoparticles within the nanotag solution was calculated to be 
11.1 pM and subsequent dilutions of the original nanotag suspension, i.e. AuNPs 
functionalised with either of the two Raman reporters, was carried out using deionised 
water until no SORS signal from either of the reporter molecules was observed. All 
measurements were carried out using a handheld SORS instrument using a total 
exposure time of 10 seconds (2 s integration time, 5 accumulations). The nose cone 
was fitted to use the instrument in a contact mode setting. The handheld instrument 
used here has a fixed maximum exposure time, therefore it should be noted that if 
longer acquisition times were used, the signal to noise ratio may be improved and 
greater limits of detection could potentially be achieved. To investigate the LOD for 
each of the two nanotags, solutions with each reporter were held in a quartz 
microcuvette. Porcine tissue samples of a 5 mm thickness were placed in front of the 
cuvette and brought into contact with the laser, leaving no space between the nose 
cone and the sample (supporting information, Figure S1). The peaks at 1204 cm-1 and 
1592 cm-1 were used to calculate the LODs for BPE and dye 823 nanotags 
respectively since these were the strongest peaks. Spectra were acquired at an 8 mm 
spatial offset and truncated and baselined and the peak height at either 1204 cm-1 or 
1592 cm-1 was measured at each concentration. We have previously shown that an 8 
mm offset results in the greatest level of through barrier detection.7  This is the 
maximum capability of the handheld instrument, i.e. spatial offsets greater than 8 mm 
cannot be achieved using this instrument. 
 
 
The potential of BPE or dye 823 nanotags for use in in vivo applications was then 
assessed. Figure S2 (supporting information) shows the tracking of BPE nanotags 
through 5 mm of tissue at a concentration of 11 pM (middle spectrum) using an 8 mm 
offset. The BPE and tissue reference spectra are shown at the top and bottom 
respectively. The spectral features that correspond to BPE can be clearly seen at this 
concentration, specifically the peak at 1204 cm-1. However, when the particles were 
diluted further, i.e. to a concentration of 10 pM, they failed to produce a SERS 
response and the resulting spectra corresponded to that of the tissue alone. Therefore, 
it was only possible to state an observable LOD of 11 pM through 5 mm of tissue using 
BPE nanotags. The sensitivity of BPE nanotags was then compared to nanotags 
containing dye 823. Figure 2a shows the detection of dye 823 nanotags at a 
concentration of 6 pM through 5 mm of tissue using an 8 mm offset (middle spectrum). 
The dye reference spectrum is displayed at the top and the tissue reference spectrum 
at the bottom. Clear detection of the nanotags can be observed at this concentration 
with almost no spectral contribution from the tissue section observed in the offset 
spectra, thus demonstrating the efficiency of dye 823 nanotags at a concentration of 
6 pM. Figure 2b shows the particle dilution study of dye 823 nanotag solution through 
5 mm of tissue. The LOD was calculated over a range of 6 to 1 pM using the height of 
the peak at 1592 cm-1. Figure 2b shows that a linear response was obtained and the 
observable LOD was 1 pM. The theoretical LOD was calculated to be 104 fM. This 
was achieved by multiplying the standard deviation of the blank three times and 
dividing it by the gradient of the straight line, which can be observed in Figure 2b. 
Tissue spectra collected at an 8 mm offset were used as the blank (supporting 
information, Figure S3). Offset spectra were used as the blank to account for poorer 
resolution and signal to noise when using spectra collected at an 8 mm offset. The 
peak intensity of 1592 cm-1 is also plotted in Figure 2c and shows the decline in peak 
intensity as the concentration of the nanotag is reduced. Therefore, it can be stated 
that the observable limit of detection of nanotags through 5 mm of tissue using 
SESORS containing dye 823 is eleven times higher than nanotags containing BPE, 
i.e. 1 pM (dye 823) compared to 11 pM (BPE). Furthermore, it should be noted that if 
an additional tissue section was placed behind the cuvette, it is probable that even 
lower limits of detection would have been achieved since it would help to facilitate the 
return of scattered Raman photons to the collection optics. 
 
 
 
 Figure 2(a) – Dye 823 nanotags at a concentration of 6 pM obscured by 5 mm of tissue (middle). Dye 823 
and tissue reference spectra for the tracking of dye 823 nanotag solution through 5 mm of tissue. The 
tissue and dye 823 reference spectra are shown at the bottom and top respectively. The middle spectrum 
represents the Raman signal collected at an 8 mm offset through 5 mm of tissue. Nanotags were obscured 
by 5 mm of tissue and held in a quartz microcuvette. (b) SERS particle dilution study for dye 823 nanotags 
obscured by 5 mm tissue over the concentration range of 6 pM to 1 pM. From the graph, the observed limit 
of detection of nanotags containing dye 823 is 1 pM. The theoretical limit of detection was calculated to be 
104 fM. The limit of detection was determined by calculating the peak intensity at 1592 cm-1 in the 8 mm 
offset spectra. Nanotags were obscured by 5 mm of tissue and held in a quartz microcuvette. (c) The peak 
intensity at 1592 cm-1. Peak intensities were obtained by scanning 3 replicate samples, 5 times. The average 
peak intensity for each of the 5 dyes is shown and error bars represent ± one standard deviation. All 
measurements were carried out using a 2 s integration time, 5 accumulations, 830 nm laser excitation 
wavelength. 
 
The chalcogen nanotag, which is in resonance with the laser wavelength of 830 nm, 
produces highly intense SERRS spectra due to its highly aromatic structure. Thus, by 
making use of the SORS technique, it is possible to obtain a vibrational fingerprint of 
dye 823 nanotags at low concentrations, even when obscuring tissue barriers are 
present. Dye 823 also has a larger Raman cross section in comparison to BPE, making 
it a superior Raman scatterer as well as being in resonance with the excitation 
wavelength.23 Figure 3(a) shows the 8 mm offset spectra of BPE nanotags (green) 
and dye 823 nanotags (purple) at a concentration of 11 pM. As shown, there is a clear 
difference in the signal to noise ratio between the two nanotags. The resonant Raman 
reporter produces clearly observable spectra with excellent signal to noise. This is in 
contrast to the spectra collected of the BPE nanotags at the same concentration 
through 5 mm of tissue, in which several spectral features correspond to that of the 
tissue (supporting information, Figure S3). The relative peak intensities of the most 
intense peak that corresponds to that of either nanotag, 1592 cm-1 (dye 823) and 1204 
cm-1 (BPE), are also shown, Figure 3b. Dye 823 generated the strongest intensity and 
is therefore assigned an intensity value of 100%. The relative peak intensity refers to 
the peak intensity of nanotags containing BPE obscured by 5 mm of tissue, relative to 
the peak intensity observed using dye 823, expressed as a percentage. As shown, 
there is almost a 100% increase in signal when a resonant Raman reporter is used at 
a nanotag concentration of 11 pM. Thus, the benefit of red-shifted chalcogenpyrylium 
Raman reporters for ultra-sensitive SESORS applications, is further demonstrated. 
 
 
 
 
Figure 3 – (a) Scaled 8 mm offset spectra of 11 pM BPE nanotags (top) and dye 823 nanotags (bottom) 
obscured by 5 mm of tissue. (b) Bar chart showing average peak intensities of dye 823 and BPE at 1592 
cm-1 and 1204 cm-1 respectively, as well as the relative percentage peak intensity relative to the most 
intense signal from dye 823, through 5 mm of tissue. Nanotag solutions were held in a cuvette and the 
cuvette was placed behind tissue samples. Peak intensities were obtained by scanning 3 replicate 
samples, 5 times and error bars represent one standard deviation. All measurements were carried out 
using a 2 s integration time, 5 accumulations, 830 nm laser excitation wavelength. 
 
By ultilising a resonant chalcogenpyrylium Raman reporter for SESORRS 
applications, superior limits of detection can be achieved in contrast to commercially 
available non-resonant small molecules. The observable limits of detection for 
nanotags containing dye 823 are eleven times greater than what is seen when 
nanotags containing BPE are obscured by 5 mm of tissue, i.e 1 pM in comparison to 
11 pM respectively. The work presented here explores the benefit of using resonant 
Raman reporters for superior low level limits of detection of SERRS nanotags using 
the SORS technique. It demonstrates the suitability of red-shifted nanotags for 
biomedical imaging applications where it may be important to keep the nanotag 
concentration as low as possible. Furthermore, if nanoparticles were used to target a 
tumour, their accumulation within the tumour would also be low, particularly if they are 
administered systemically. Therefore, it is important to understand the number of 
nanoparticles that can be detected at a given depth and also to establish the minimum 
concentration of nanotags required for SERRS response at a given depth using 
SORS. In addition, the average thickness of skin on breast tissue ranges from 0.5 mm 
to 3 mm, 30 thus making the detection of SERRS nanotags at low level concentrations 
through 5 mm of tissue significant. Future work will focus on establishing the minimum 
concentration of dye 823 nanotags required to produce a SERRS response at larger, 
more clinically relevant depths using SORS as well as investigating the use of red 
shifted nanomaterials for SESORRS applications.  
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